ARKORELAX SOMMEIL FAMILLE, flacon
Food supplement declared in France, decision dated 10 November 2025
ARKORELAX SOMMEIL FAMILLE, flacon (ARKOPHARMA) is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: Matricaria chamomilla 800 mg per day, Tilia tomentosa 412 mg per day, Papaver rhoeas 90 mg per day, Aloysia citriodora 5.82 g per day. None of the rules we check flags an issue with its declared composition.
- Brand
- ARKOPHARMA
- Food business operator placing the product on the market
- LABORATOIRES ARKOPHARMA
- Status
- Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
- Form
- Bottle
- Daily dose
- 20 ml
- Directions for use
- De 1-3 ans : 5 ml / De 4-6 ans : 7,5 ml / De 7-11 ans : 10 ml / Dès 12 ans : 20 ml
- Intended populations
- Young children aged 1 to 3, Children aged 4 to 10, Adolescents aged 11 to 17, Men and women aged 18 and over, People over 60
- Not recommended (according to the manufacturer)
- Breastfeeding women, Pregnant women, Infants (under 1 year)
- Objectives stated by the manufacturer (these are not authorised claims)
- Respiratory tract, Digestion, Sleep
- Flavourings
- Fraine-Banane
Declaration 343762, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Matricaria chamomilla L. | Fleur | Extrait sec aqueux | 800 mg |
| Tilia tomentosa Moench | Fleur | Extrait sec aqueux | 412 mg |
| Papaver rhoeas L. | Fleur | Extrait sec aqueux | 90 mg |
| Aloysia citriodora Palau | Feuille | Extrait fluide aqueux | 5.82 g |
Other ingredients
jus de citron, maltodextrine, sirop d'agave, sirop de riz
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
Has the product changed? Photograph the packaging.
Label warnings
Enfants à partir d’1 an. Déconseillé en cas d'allergie aux plantes de la famille des Astéracées. En cas de sommeil difficile chez un enfant de 1 à 3 ans, ou de traitement médicamenteux, il est recommandé de demander l’avis d’un professionnel de santé.
Regulatory points
None of the rules we check applies to the declared ingredients.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Matricaria chamomilla L.
Read the warning, when it applies and the studies cited
GERMAN CHAMOMILE - MATRICARIA CHAMOMILLA Oral
Route of administration: Oral (ESCOP 2003; Blumenthal et al. 2000; WHO 1999; Bradley 1992).
Cautions and warnings
When using this product exercise caution if you drive or use machinery as you may experience drowsiness.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Known adverse reactions
Stop use if hypersensitivity/allergy occurs (ESCOP 2003; Bradley 1992).
Sources cited by Health Canada (2)
- Bradley PR, editor. British Herbal Compendium, Volume 1. Bournemouth (GB): British Herbal Medicine Association; 1992.
- ESCOP 2003: European Scientific Cooperative on Phytotherapy Scientific Committee. 2003. ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (GB): European Scientific Cooperative on Phytotherapy and Thieme.
Health Canada monograph dated 19 December 2025
German Chamomile - Matricaria Chamomilla Topical
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Known adverse reactions
Stop use if hypersensitivity/allergy occurs (ESCOP 2003; Bradley 1992).
Sources cited by Health Canada (2)
- Bradley PR, editor. British Herbal Compendium, Volume 1. Bournemouth (GB): British Herbal Medicine Association; 1992.
- ESCOP 2003: European Scientific Cooperative on Phytotherapy Scientific Committee. ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (GB): European Scientific Cooperative on Phytotherapy and Thieme; 2003.
Health Canada monograph dated 31 January 2025
GERMAN CHAMOMILE - MATRICARIA CHAMOMILLA Buccal
Route of administration: Buccal (ESCOP 2003; Blumenthal et al. 2000; Bradley 1992)
Cautions and warnings
Ask a healthcare practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Known adverse reactions
Stop use if hypersensitivity/allergy occurs (ESCOP 2003; Bradley 1992).
Sources cited by Health Canada (2)
- Bradley PR, editor. British Herbal Compendium, Volume 1. Bournemouth (GB): British Herbal Medicine Association; 1992.
- ESCOP 2003: European Scientific Cooperative on Phytotherapy Scientific Committee. ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (GB): European Scientific Cooperative on Phytotherapy and Thieme; 2003.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
Brand : ARKOPHARMA
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “ARKORELAX SOMMEIL FAMILLE, flacon (ARKOPHARMA): composition and regulation”, https://compoatlas.com/en/supplements/products/343762-arkorelax-sommeil-famille-flacon, updated 15 November 2026.